CIK 0001077183
- Large accelerated filer
NEOGENOMICS INC
Sign in to watch- Ticker
- NEO
- Exchange
- Nasdaq
- Industry
- Services-Testing Laboratories
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 742897368
- Phone
- +1 239-768-0600
- Business address
- 9490 NEOGENOMICS WAY, FORT MYERS, FL, 33912
- Former names
- AMERICAN COMMUNICATIONS ENTERPRISES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-06-10 | HANNAH ALISON L. Director | Grant or award | +15,556 | 107,433 | ||
| 2022-06-10 | HANNAH ALISON L. Director | Grant or award · Stock Option (Right to Buy) | +13,882 | 13,882 | ||
| 2022-06-10 | Stahler Rachel A Director | Grant or award | +15,556 | 21,335 | ||
| 2022-06-10 | Stahler Rachel A Director | Grant or award · Stock Option (Right to Buy) | +13,882 | 13,882 | ||
| 2022-06-10 | Daly David Director | Grant or award | +15,556 | 17,179 | ||
| 2022-06-10 | Daly David Director | Grant or award · Stock Option (Right to Buy) | +13,882 | 13,882 | ||
| 2022-06-10 | TETRAULT LYNN A. Director | Grant or award | +15,556 | 54,667 | ||
| 2022-06-10 | TETRAULT LYNN A. Director | Grant or award · Stock Option (Right to Buy) | +13,882 | 13,882 | ||
| 2022-06-01 | Sikri Vishal President and CCO, Inivata | Grant or award | +148,455 | 148,455 | ||
| 2022-06-01 | Sikri Vishal President and CCO, Inivata | Grant or award · Stock Option (Right to Buy) | +319,112 | 319,112 | ||
| 2022-05-18 | TETRAULT LYNN A. Director | Option exercise | +3,334 | $7.27 | $24K | 39,111 |
| 2022-05-18 | TETRAULT LYNN A. Director | Option exercise · Stock Option (Right to Buy) | −3,334 | 0 | ||
| 2022-04-28 | Bonello William Chief Financial Officer | Option exercise | +5,727 | $7.52 | $43K | 191,548 |
| 2022-04-28 | Bonello William Chief Financial Officer | Option exercise · Stock Option (Right to Buy) | −5,727 | 0 | ||
| 2022-04-01 | Bonello William Chief Financial Officer | Grant or award | +82,305 | 185,821 | ||
| 2022-04-01 | Sholehvar David President, Clinical Services | Grant or award | +30,864 | 30,864 | ||
| 2022-04-01 | Sholehvar David President, Clinical Services | Grant or award · Stock Option (Right to Buy) | +66,372 | 66,372 | ||
| 2022-04-01 | Brown Douglas Matthew Chief Strategy Officer | Grant or award | +82,305 | 158,684 | ||
| 2022-03-08 | Bonello William Chief Financial Officer | Option exercise | +5,000 | $7.52 | $38K | 103,516 |
| 2022-03-08 | Bonello William Chief Financial Officer | Option exercise · Stock Option (Right to Buy) | −5,000 | 5,727 |
Page 20 of 23 · 447 trades